Cargando…

Immunofluorescent Localization of Plakoglobin Is Altered in Endomyocardial Biopsy Samples from Dogs with Clinically Relevant Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

Diagnosing the early stages of canine Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) is complicated by day-to-day arrhythmia variability, and absence of reliable, transthoracic echocardiographic features. Definitive diagnosis requires histopathologic identification of transmural fibrofatty r...

Descripción completa

Detalles Bibliográficos
Autores principales: Oxford, Eva M., Pariaut, Romain, Tursi, Massimiliano, Fox, Philip R., Santilli, Roberto A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623220/
https://www.ncbi.nlm.nih.gov/pubmed/34822621
http://dx.doi.org/10.3390/vetsci8110248
_version_ 1784605880035049472
author Oxford, Eva M.
Pariaut, Romain
Tursi, Massimiliano
Fox, Philip R.
Santilli, Roberto A.
author_facet Oxford, Eva M.
Pariaut, Romain
Tursi, Massimiliano
Fox, Philip R.
Santilli, Roberto A.
author_sort Oxford, Eva M.
collection PubMed
description Diagnosing the early stages of canine Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) is complicated by day-to-day arrhythmia variability, and absence of reliable, transthoracic echocardiographic features. Definitive diagnosis requires histopathologic identification of transmural fibrofatty replacement of the right ventricle. Reduction of immunofluorescent signal for plakoglobin (PG) at the intercalated disc (ID) is reported in ARVC-affected humans and boxers. Our objective was to determine whether reduced immunofluorescent signal for PG in endomyocardial biopsy samples (EMBs) correspond with a histopathologic diagnosis of ARVC. Here, 49 dogs were evaluated: 43 with advanced cardiac disease and 6 non-clinical boxers with mild to moderate ventricular arrhythmia (VA) burden. EMBs were obtained from all dogs; samples were prepared with antibodies recognizing cadherin (PC) and PG and evaluated with confocal microscopy. Investigators were blinded to breed and clinical status. ARVC was histopathologically diagnosed in 8 out of 49 dogs. Of these, three out of eight had clinical signs consistent with ARVC (two boxers, one English bulldog) and reduced PG signal at ID; five out of eight were non-clinical boxers with moderate VA and no reduction in PG. A total of 41 out of 49 dogs were histopathologically diagnosed with non-ARVC cardiac disease; 1 out of 41 showed reduction of PG at ID, while 40 out of 41 had no PG reduction. These results suggest that EMB PG signal is reduced in dogs with advanced ARVC, but not in the occult phase of the disease. Additionally, presence of PG at ID supports a diagnosis of non-ARVC cardiac disease in dogs with clinical signs. These results may offer an additional test that helps differentiate advanced ARVC from other myocardial diseases.
format Online
Article
Text
id pubmed-8623220
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86232202021-11-27 Immunofluorescent Localization of Plakoglobin Is Altered in Endomyocardial Biopsy Samples from Dogs with Clinically Relevant Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) Oxford, Eva M. Pariaut, Romain Tursi, Massimiliano Fox, Philip R. Santilli, Roberto A. Vet Sci Article Diagnosing the early stages of canine Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) is complicated by day-to-day arrhythmia variability, and absence of reliable, transthoracic echocardiographic features. Definitive diagnosis requires histopathologic identification of transmural fibrofatty replacement of the right ventricle. Reduction of immunofluorescent signal for plakoglobin (PG) at the intercalated disc (ID) is reported in ARVC-affected humans and boxers. Our objective was to determine whether reduced immunofluorescent signal for PG in endomyocardial biopsy samples (EMBs) correspond with a histopathologic diagnosis of ARVC. Here, 49 dogs were evaluated: 43 with advanced cardiac disease and 6 non-clinical boxers with mild to moderate ventricular arrhythmia (VA) burden. EMBs were obtained from all dogs; samples were prepared with antibodies recognizing cadherin (PC) and PG and evaluated with confocal microscopy. Investigators were blinded to breed and clinical status. ARVC was histopathologically diagnosed in 8 out of 49 dogs. Of these, three out of eight had clinical signs consistent with ARVC (two boxers, one English bulldog) and reduced PG signal at ID; five out of eight were non-clinical boxers with moderate VA and no reduction in PG. A total of 41 out of 49 dogs were histopathologically diagnosed with non-ARVC cardiac disease; 1 out of 41 showed reduction of PG at ID, while 40 out of 41 had no PG reduction. These results suggest that EMB PG signal is reduced in dogs with advanced ARVC, but not in the occult phase of the disease. Additionally, presence of PG at ID supports a diagnosis of non-ARVC cardiac disease in dogs with clinical signs. These results may offer an additional test that helps differentiate advanced ARVC from other myocardial diseases. MDPI 2021-10-23 /pmc/articles/PMC8623220/ /pubmed/34822621 http://dx.doi.org/10.3390/vetsci8110248 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Oxford, Eva M.
Pariaut, Romain
Tursi, Massimiliano
Fox, Philip R.
Santilli, Roberto A.
Immunofluorescent Localization of Plakoglobin Is Altered in Endomyocardial Biopsy Samples from Dogs with Clinically Relevant Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
title Immunofluorescent Localization of Plakoglobin Is Altered in Endomyocardial Biopsy Samples from Dogs with Clinically Relevant Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
title_full Immunofluorescent Localization of Plakoglobin Is Altered in Endomyocardial Biopsy Samples from Dogs with Clinically Relevant Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
title_fullStr Immunofluorescent Localization of Plakoglobin Is Altered in Endomyocardial Biopsy Samples from Dogs with Clinically Relevant Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
title_full_unstemmed Immunofluorescent Localization of Plakoglobin Is Altered in Endomyocardial Biopsy Samples from Dogs with Clinically Relevant Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
title_short Immunofluorescent Localization of Plakoglobin Is Altered in Endomyocardial Biopsy Samples from Dogs with Clinically Relevant Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
title_sort immunofluorescent localization of plakoglobin is altered in endomyocardial biopsy samples from dogs with clinically relevant arrhythmogenic right ventricular cardiomyopathy (arvc)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623220/
https://www.ncbi.nlm.nih.gov/pubmed/34822621
http://dx.doi.org/10.3390/vetsci8110248
work_keys_str_mv AT oxfordevam immunofluorescentlocalizationofplakoglobinisalteredinendomyocardialbiopsysamplesfromdogswithclinicallyrelevantarrhythmogenicrightventricularcardiomyopathyarvc
AT pariautromain immunofluorescentlocalizationofplakoglobinisalteredinendomyocardialbiopsysamplesfromdogswithclinicallyrelevantarrhythmogenicrightventricularcardiomyopathyarvc
AT tursimassimiliano immunofluorescentlocalizationofplakoglobinisalteredinendomyocardialbiopsysamplesfromdogswithclinicallyrelevantarrhythmogenicrightventricularcardiomyopathyarvc
AT foxphilipr immunofluorescentlocalizationofplakoglobinisalteredinendomyocardialbiopsysamplesfromdogswithclinicallyrelevantarrhythmogenicrightventricularcardiomyopathyarvc
AT santillirobertoa immunofluorescentlocalizationofplakoglobinisalteredinendomyocardialbiopsysamplesfromdogswithclinicallyrelevantarrhythmogenicrightventricularcardiomyopathyarvc